Skip to main content
Erschienen in: Journal of General Internal Medicine 4/2012

01.04.2012 | Original Research

The Effects of Financial Pressures on Adherence and Glucose Control Among Racial/Ethnically Diverse Patients with Diabetes

verfasst von: Quyen Ngo-Metzger, MD, MPH, Dara H. Sorkin, PhD, John Billimek, PhD, Sheldon Greenfield, MD, Sherrie H. Kaplan, PhD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

ABSTRACT

Background

The Affordable Care Act is designed to decrease the numbers of uninsured patients in U.S. However, even with insurance, patients who have financial hardships may have difficulty obtaining their medications because of cost issues.

Objective

Among patients with type 2 diabetes, to examine the association between patients’ self-reported financial pressures on cost-related medication non-adherence and glucose control. Additionally, to examine whether having insurance decrease the financial pressures of diabetes care.

Design and Participants

Racially/ethnically diverse patients (N = 1,361; 249 non-Hispanic whites, 194 Vietnamese, and 533 Mexican American) with type 2 diabetes were recruited from seven outpatient clinics for a cross-sectional, observational study.

Key Results

Although both Vietnamese and Mexican-American patients reported having low annual incomes, more Mexican Americans reported the presence of financial barriers to getting medical care and perceived financial burden due to their diabetes, compared to whites and Vietnamese (p < 0.001). Over half (53.2%) of Mexican Americans reported cost-related non-adherence compared to 27.2% of white and 27.6% of Vietnamese patients (p < 0.001). Perceived financial burden was found to be associated with poor glucose control (HbA1c ≥8%), after adjusting for sociodemographic and health characteristics (aOR = 1.70, 95%CI 1.09-2.63), but not when adjusting for non-adherence. Similarly, a significant association between presence of financial barriers and HbA1c (aOR = 1.69, 95%CI 1.23-2.32) was attenuated with the inclusion of insurance status in the model. Being uninsured (aOR = 1.90, 95%CI 1.13-3.21) and non-adherent (aOR = 1.49, 95%CI 1.06-2.08) were each independently associated with HbA1c.

Conclusions

While having health insurance coverage eliminated some of the financial barriers associated with having diabetes, low-income patients still faced significant financial burdens. Thus, providing health insurance to more individuals is only the first step towards eliminating health disparities. It is important to address medication cost in order to improve medication adherence and glucose control.
Literatur
1.
Zurück zum Zitat DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health Insurance Coverage in the United States: 2009, in Current Population Reports, P60-238, U.S. Census Bureau, Editor. Washington, DC; 2010. DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health Insurance Coverage in the United States: 2009, in Current Population Reports, P60-238, U.S. Census Bureau, Editor. Washington, DC; 2010.
2.
Zurück zum Zitat Kirby J, Taliaferro G, Zuvekas SH. Explaining racial and ethnic disparities in health care. Medical care. 2006;44(5):I-64–72. Kirby J, Taliaferro G, Zuvekas SH. Explaining racial and ethnic disparities in health care. Medical care. 2006;44(5):I-64–72.
3.
Zurück zum Zitat Hargraves JL, Hadley J. The contribution of insurance coverage and community resources to reducing racial/ethnic disparities in access to care. Health Serv Res. 2003;38(3):809–829.PubMedCrossRef Hargraves JL, Hadley J. The contribution of insurance coverage and community resources to reducing racial/ethnic disparities in access to care. Health Serv Res. 2003;38(3):809–829.PubMedCrossRef
4.
Zurück zum Zitat Heisler M, et al. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853–1860.PubMedCrossRef Heisler M, et al. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853–1860.PubMedCrossRef
5.
Zurück zum Zitat Harris MI. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care. 2001;24(3):454–9.PubMedCrossRef Harris MI. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care. 2001;24(3):454–9.PubMedCrossRef
6.
Zurück zum Zitat Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27(2):384–391.PubMedCrossRef Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27(2):384–391.PubMedCrossRef
9.
Zurück zum Zitat Greenfield S, et al. The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. Diabetes Care. 1994;17(Suppl 1):32–9.PubMed Greenfield S, et al. The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. Diabetes Care. 1994;17(Suppl 1):32–9.PubMed
10.
Zurück zum Zitat Soumerai SB. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006;166(17):1829–35.PubMedCrossRef Soumerai SB. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006;166(17):1829–35.PubMedCrossRef
11.
Zurück zum Zitat Safran DG, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005, Suppl Web Exclusives, p. W5-152-W5-166. Safran DG, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005, Suppl Web Exclusives, p. W5-152-W5-166.
12.
Zurück zum Zitat Wilson IB, et al. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study. J Gen Intern Med. 2005;20(8):715–20.PubMedCrossRef Wilson IB, et al. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study. J Gen Intern Med. 2005;20(8):715–20.PubMedCrossRef
13.
Zurück zum Zitat Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef
14.
Zurück zum Zitat Greenfield S. Development and testing of a new measure of case mix for use in office practice. Med Care. 1995;33(4):AS47–55.PubMed Greenfield S. Development and testing of a new measure of case mix for use in office practice. Med Care. 1995;33(4):AS47–55.PubMed
15.
Zurück zum Zitat Thom DH, et al. Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. Med Care. 1999;37(5):510–7.PubMedCrossRef Thom DH, et al. Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. Med Care. 1999;37(5):510–7.PubMedCrossRef
16.
Zurück zum Zitat Bullinger M, et al. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International quality of life assessment. J Clin Epidemiol. 1998;51(11):913–23.PubMedCrossRef Bullinger M, et al. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International quality of life assessment. J Clin Epidemiol. 1998;51(11):913–23.PubMedCrossRef
17.
Zurück zum Zitat Fowler FJ. Improving Survey Questions: Design and Evaluation. Newbury Park: Sage Publications; 1995. Fowler FJ. Improving Survey Questions: Design and Evaluation. Newbury Park: Sage Publications; 1995.
18.
Zurück zum Zitat Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864–71.PubMedCrossRef Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864–71.PubMedCrossRef
19.
Zurück zum Zitat Piette JD, et al. The role of patient–physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165(15):1749–1755.PubMedCrossRef Piette JD, et al. The role of patient–physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165(15):1749–1755.PubMedCrossRef
20.
Zurück zum Zitat Kurlander JE, et al. Cost-related nonadherence to medications among patients with diabetes and chronic pain: factors beyond finances. Diabetes Care. 2009;32(12):2143–8.PubMedCrossRef Kurlander JE, et al. Cost-related nonadherence to medications among patients with diabetes and chronic pain: factors beyond finances. Diabetes Care. 2009;32(12):2143–8.PubMedCrossRef
21.
Zurück zum Zitat Tseng CW, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the translating research into action for diabetes study. Diabetes Care. 2008;31(2):261–6.PubMedCrossRef Tseng CW, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the translating research into action for diabetes study. Diabetes Care. 2008;31(2):261–6.PubMedCrossRef
22.
Zurück zum Zitat Piette JD, Heisler M, Wagner TH. Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol. 2006;59(7):739–46.PubMedCrossRef Piette JD, Heisler M, Wagner TH. Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol. 2006;59(7):739–46.PubMedCrossRef
23.
Zurück zum Zitat Wagner TH, Heisler M, Piette JD. Prescription drug co-payments and cost-related medication underuse. Health Econ Policy Law. 2008;3(Pt 1):51–67.PubMed Wagner TH, Heisler M, Piette JD. Prescription drug co-payments and cost-related medication underuse. Health Econ Policy Law. 2008;3(Pt 1):51–67.PubMed
24.
Zurück zum Zitat Piette JD, et al. Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse. J Health Care Poor Underserved. 2010;21(1):349–61.PubMedCrossRef Piette JD, et al. Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse. J Health Care Poor Underserved. 2010;21(1):349–61.PubMedCrossRef
Metadaten
Titel
The Effects of Financial Pressures on Adherence and Glucose Control Among Racial/Ethnically Diverse Patients with Diabetes
verfasst von
Quyen Ngo-Metzger, MD, MPH
Dara H. Sorkin, PhD
John Billimek, PhD
Sheldon Greenfield, MD
Sherrie H. Kaplan, PhD, MPH
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 4/2012
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1910-7

Weitere Artikel der Ausgabe 4/2012

Journal of General Internal Medicine 4/2012 Zur Ausgabe

Clinical Practice: Clinical Images

ST-Segment Elevation and Minimally Reactive Pupils

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.